Evidence map›Paper›PMID 33389634›Full record

ArticleVirus genes2021

PK15 cell line stably overexpressing IL2 enhances PCV2 replication.

Xuliang Zhang, Yingfeng Zhao, Chang Ma, Jinwei You, Min Dong, Shifeng Yun, Jie Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Virus genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xuliang ZhangDepartment of Comparative Medicine, Jinling Hospital, Nanjing, People's Republic of China.
Yingfeng ZhaoThe Third Outpatient Department, Jinling Hospital, Nanjing, People's Republic of China.
Chang MaDepartment of Comparative Medicine, Jinling Hospital, Nanjing, People's Republic of China.
Jinwei YouDepartment of Comparative Medicine, Jinling Hospital, Nanjing, People's Republic of China.
Min DongDepartment of Comparative Medicine, Jinling Hospital, Nanjing, People's Republic of China.
Shifeng YunDepartment of Comparative Medicine, Jinling Hospital, Nanjing, People's Republic of China. ysf_nj@126.com.
Jie LiuDepartment of Comparative Medicine, Jinling Hospital, Nanjing, People's Republic of China. jieliucn@vip.163.com.ORCID http://orcid.org/0000-0002-6728-8550

Funding

National Natural Science Foundation of China (CN) 31502063
6 · The paper itself

Abstract

Porcine circovirus type 2 (PCV2) is the primary agent responsible for porcine circovirus-associated diseases (PCVADs), which is acknowledged as one of the most economically important diseases for the swine industry worldwide. Currently, the development of PCV2 vaccine against PCVADs and for other applications require large amounts of viral particles. The low propagation rate of PCV2 in vitro limits vaccine production. Previous studies showed that a cell line transfected with the porcine interleukin (IL)-2 gene gave higher PCV2 yield in vitro. However, transient transfection may become less effective and unstable after serial generations. In this work, we constructed a PK15 cell line with stable expression of porcine IL2 by lentivirus transfection. The results demonstrated that the transgenic cell line stably expressed IL2 protein significantly enhanced PCV2 replication. Thus, the transgenic PK15 cell line could be a promising cell line for vaccine production.

Indexed as

Virus ReplicationAnimalsCell LineCircoviridae InfectionsCircovirusInterleukin-2SwineSwine DiseasesInterleukin-2IL2PCV2Stably cell lineViral propagation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.